Literature DB >> 16803940

Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation.

C M C van Campen1, F C Visser, C C de Cock, H S Vos, O Kamp, C A Visser.   

Abstract

BACKGROUND: Biventricular pacing is a new therapy for the treatment of heart failure. However, a substantial number of patients do not respond to this therapy. HYPOTHESIS: Individually determined maximal pacing sites will improve the haemodynamic response and increase the number of responders.
METHODS: In 48 patients with heart failure, the acute haemodynamic effects of nine different pacing configurations were studied, using two right and left ventricular pacing sites and their combinations. Cardiac index was measured using Doppler echocardiography. For further analysis, the combination with the highest cardiac index improvement was compared with baseline. Moreover, the number of responders was calculated using a cut-off value of 10% increase in cardiac index.
RESULTS: The mean (SD) increase in cardiac index ranged between 3.8% (6.0%) and 11.1% (8.6%). The pacing site with maximal cardiac index was highly variable between patients, and here the cardiac index increased to 14.8% (7.6%; (p<0.001). The number of responders varied between 15% and 64%, increasing to 75% at the site with maximal increase in cardiac index. In a subset of patients, the haemodynamic improvement after pacemaker implantation correlated well with the acute haemodynamics.
CONCLUSION: Individualisation of pacing configuration for biventricular pacing leads to further haemodynamic improvement in patients with heart failure and reduces the number of patients not responding to this therapy.

Entities:  

Mesh:

Year:  2006        PMID: 16803940      PMCID: PMC1861309          DOI: 10.1136/hrt.2004.050435

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  36 in total

1.  A pilot experience with permanent biventricular pacing to treat advanced heart failure.

Authors:  C Leclercq; S Cazeau; P Ritter; C Alonso; D Gras; P Mabo; A Lazarus; J C Daubert
Journal:  Am Heart J       Date:  2000-12       Impact factor: 4.749

2.  Comparison of characteristics in responders versus nonresponders with biventricular pacing for drug-resistant congestive heart failure.

Authors:  Sylvain Reuter; Stephane Garrigue; S Serge Barold; Pierre Jais; Meleze Hocini; Michel Haissaguerre; Jacques Clementy
Journal:  Am J Cardiol       Date:  2002-02-01       Impact factor: 2.778

3.  Echocardiographic prediction of long-term response to biventricular pacemaker in severe heart failure.

Authors:  Enis Oguz; Bahadir Dagdeviren; Tuba Bilsel; Osman Akdemir; Izzet Erdinler; Ahmet Akyol; Tanju Ulufer; Tuna Tezel; Kadir Gurkan
Journal:  Eur J Heart Fail       Date:  2002-01       Impact factor: 15.534

4.  Effect of resynchronization therapy stimulation site on the systolic function of heart failure patients.

Authors:  C Butter; A Auricchio; C Stellbrink; E Fleck; J Ding; Y Yu; E Huvelle; J Spinelli
Journal:  Circulation       Date:  2001-12-18       Impact factor: 29.690

5.  Exercise performance following cardiac resynchronization therapy in patients with heart failure and ventricular conduction delay.

Authors:  Angelo Auricchio; Michael Kloss; Silke Isabelle Trautmann; Susanne Rodner; Helmut Klein
Journal:  Am J Cardiol       Date:  2002-01-15       Impact factor: 2.778

6.  Biventricular pacing decreases sympathetic activity compared with right ventricular pacing in patients with depressed ejection fraction.

Authors:  M H Hamdan; J D Zagrodzky; J A Joglar; C J Sheehan; K Ramaswamy; J F Erdner; R L Page; M L Smith
Journal:  Circulation       Date:  2000-08-29       Impact factor: 29.690

7.  Ventricular contraction abnormalities in dilated cardiomyopathy: effect of biventricular pacing to correct interventricular dyssynchrony.

Authors:  W F Kerwin; E H Botvinick; J W O'Connell; S H Merrick; T DeMarco; K Chatterjee; K Scheibly; L A Saxon
Journal:  J Am Coll Cardiol       Date:  2000-04       Impact factor: 24.094

8.  Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block.

Authors:  G S Nelson; R D Berger; B J Fetics; M Talbot; J C Spinelli; J M Hare; D A Kass
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

9.  Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study.

Authors:  J J Blanc; Y Etienne; M Gilard; J Mansourati; S Munier; J Boschat; D G Benditt; K G Lurie
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

10.  Electrocardiographic predictive factors of long-term clinical improvement with multisite biventricular pacing in advanced heart failure.

Authors:  C Alonso; C Leclercq; F Victor; H Mansour; C de Place; D Pavin; F Carré; P Mabo; J C Daubert
Journal:  Am J Cardiol       Date:  1999-12-15       Impact factor: 2.778

View more
  12 in total

Review 1.  How to improve outcomes with cardiac resynchronisation therapy: importance of lead positioning.

Authors:  Peter J Cowburn; Christophe Leclercq
Journal:  Heart Fail Rev       Date:  2012-11       Impact factor: 4.214

Review 2.  Cardiac resynchronization therapy: Dire need for targeted left ventricular lead placement and optimal device programming.

Authors:  Sokratis Pastromas; Antonis S Manolis
Journal:  World J Cardiol       Date:  2014-12-26

Review 3.  Multisite pacing via a quadripolar lead for cardiac resynchronization therapy.

Authors:  Alexandre Bodin; Arnaud Bisson; Clémentine Andre; Bertrand Pierre; Laurent Fauchier; Dominique Babuty; Nicolas Clementy
Journal:  J Interv Card Electrophysiol       Date:  2019-07-18       Impact factor: 1.900

4.  Bifocal right ventricular pacing: an alternative way to achieve resynchronization when left ventricular lead insertion is unsuccessful.

Authors:  Skevos Sideris; Constantina Aggeli; Emmanouil Poulidakis; Kostas Gatzoulis; Ioannis Vlaseros; Katerina Avgeropoulou; Ioannis Felekos; Ilias Sotiropoulos; Christodoulos Stefanadis; Ioannis Kallikazaros
Journal:  J Interv Card Electrophysiol       Date:  2012-05-03       Impact factor: 1.900

5.  Computer model for the optimization of AV and VV delay in cardiac resynchronization therapy.

Authors:  Matthias Reumann; Dima Farina; Raz Miri; Stephan Lurz; Brigitte Osswald; Olaf Dössel
Journal:  Med Biol Eng Comput       Date:  2007-07-27       Impact factor: 2.602

6.  Measurement of QRS duration for biventricular pacing optimization.

Authors:  Catherine M Albright; T Alexander Quinn; George Berberian; Santos E Cabreriza; Cara A Garofalo; Alan D Weinberg; Jose M Dizon; Henry M Spotnitz
Journal:  ASAIO J       Date:  2008 Jul-Aug       Impact factor: 2.872

7.  Adverse response to cardiac resynchronisation therapy in patients with septal scar on cardiac MRI preventing a septal right ventricular lead position.

Authors:  Simon G Duckett; Matthew Ginks; Anoop Shetty; Senthil Kirubakaran; Julian Bostock; Stam Kapetanakis; Jaswinder Gill; Gerry Carr-White; Reza Razavi; C Aldo Rinaldi
Journal:  J Interv Card Electrophysiol       Date:  2011-11-30       Impact factor: 1.900

8.  Cerebral Blood Flow Is Reduced in Severe Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients During Mild Orthostatic Stress Testing: An Exploratory Study at 20 Degrees of Head-Up Tilt Testing.

Authors:  C Linda M C van Campen; Peter C Rowe; Frans C Visser
Journal:  Healthcare (Basel)       Date:  2020-06-13

9.  Orthostatic Symptoms and Reductions in Cerebral Blood Flow in Long-Haul COVID-19 Patients: Similarities with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome.

Authors:  C Linda M C van Campen; Peter C Rowe; Frans C Visser
Journal:  Medicina (Kaunas)       Date:  2021-12-24       Impact factor: 2.430

10.  Compression Stockings Improve Cardiac Output and Cerebral Blood Flow during Tilt Testing in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) Patients: A Randomized Crossover Trial.

Authors:  C Linda M C van Campen; Peter C Rowe; Frans C Visser
Journal:  Medicina (Kaunas)       Date:  2021-12-29       Impact factor: 2.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.